Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Teresa Voso

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
Blood|August 4, 2022
AML: making residual disease more measurableMaria Teresa Voso, Francesco Buccisano
Hematology. American Society of Hematology. Education Program|December 10, 2021
Have we reached a molecular era in myelodysplastic syndromes?Maria Teresa Voso, Carmelo Gurnari
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and DifferencesGiuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
Leukemia Research|November 24, 2012
Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?Massimo Breccia, Maria Teresa Voso, Giuliana Alimena
Expert Opinion on Pharmacotherapy|November 29, 2021
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children?Carmelo Gurnari, Mariadomenica Divona, Maria Teresa Voso
Blood|April 20, 2021
What's new in the pathogenesis and treatment of therapy-related myeloid neoplasmsMaria Teresa Voso, Giulia Falconi, Emiliano Fabiani
Oncotarget|December 17, 2017
Progress and criticalities in the management of acute promyelocytic leukemiaFrancesco Lo-Coco, Laura Cicconi, Maria Teresa Voso
Current Opinion in Oncology|September 10, 2015
Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemiaMaria Teresa Voso, Francesco Lo-Coco, Luana Fianchi
Haematologica|December 24, 2002
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemiasGiuseppe Leone, Luciana Teofili, Maria Teresa Voso, et al.
Clinical Immunology (Orlando, Fla.)|October 31, 2003
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDSGiuseppe Leone, Maria Teresa Voso, Luciana Teofili, et al.
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
Blood|August 4, 2022
AML: making residual disease more measurableMaria Teresa Voso, Francesco Buccisano
Hematology. American Society of Hematology. Education Program|December 10, 2021
Have we reached a molecular era in myelodysplastic syndromes?Maria Teresa Voso, Carmelo Gurnari
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and DifferencesGiuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
Leukemia Research|November 24, 2012
Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far?Massimo Breccia, Maria Teresa Voso, Giuliana Alimena
Expert Opinion on Pharmacotherapy|November 29, 2021
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children?Carmelo Gurnari, Mariadomenica Divona, Maria Teresa Voso
Blood|April 20, 2021
What's new in the pathogenesis and treatment of therapy-related myeloid neoplasmsMaria Teresa Voso, Giulia Falconi, Emiliano Fabiani
Oncotarget|December 17, 2017
Progress and criticalities in the management of acute promyelocytic leukemiaFrancesco Lo-Coco, Laura Cicconi, Maria Teresa Voso
Current Opinion in Oncology|September 10, 2015
Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemiaMaria Teresa Voso, Francesco Lo-Coco, Luana Fianchi
Haematologica|December 24, 2002
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemiasGiuseppe Leone, Luciana Teofili, Maria Teresa Voso, et al.
Clinical Immunology (Orlando, Fla.)|October 31, 2003
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDSGiuseppe Leone, Maria Teresa Voso, Luciana Teofili, et al.
Pageof 26